These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 32820807)

  • 1. Empiric Antibacterial Therapy and Community-onset Bacterial Coinfection in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19): A Multi-hospital Cohort Study.
    Vaughn VM; Gandhi TN; Petty LA; Patel PK; Prescott HC; Malani AN; Ratz D; McLaughlin E; Chopra V; Flanders SA
    Clin Infect Dis; 2021 May; 72(10):e533-e541. PubMed ID: 32820807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors and outcomes associated with community-onset and hospital-acquired coinfection in patients hospitalized for coronavirus disease 2019 (COVID-19): A multihospital cohort study.
    Petty LA; Flanders SA; Vaughn VM; Ratz D; O'Malley M; Malani AN; Washer L; Kim T; Kocher KE; Kaatz S; Czilok T; McLaughlin E; Prescott HC; Chopra V; Gandhi T
    Infect Control Hosp Epidemiol; 2022 Sep; 43(9):1184-1193. PubMed ID: 34308805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-Onset Bacterial Coinfection in Children Critically Ill With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Moffitt KL; Nakamura MM; Young CC; Newhams MM; Halasa NB; Reed JN; Fitzgerald JC; Spinella PC; Soma VL; Walker TC; Loftis LL; Maddux AB; Kong M; Rowan CM; Hobbs CV; Schuster JE; Riggs BJ; McLaughlin GE; Michelson KN; Hall MW; Babbitt CJ; Cvijanovich NZ; Zinter MS; Maamari M; Schwarz AJ; Singh AR; Flori HR; Gertz SJ; Staat MA; Giuliano JS; Hymes SR; Clouser KN; McGuire J; Carroll CL; Thomas NJ; Levy ER; Randolph AG
    Open Forum Infect Dis; 2023 Mar; 10(3):ofad122. PubMed ID: 36968962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.
    Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP
    Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and risk factors for clinically confirmed secondary bacterial infections in patients hospitalized for coronavirus disease 2019 (COVID-19).
    Park HS; McCracken CM; Lininger N; Varley CD; Sikka MK; Evans C; Villamagna AH; Makadia JT; McGregor JC
    Infect Control Hosp Epidemiol; 2023 Oct; 44(10):1650-1656. PubMed ID: 37184033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic Use and Bacterial Infection among Inpatients in the First Wave of COVID-19: a Retrospective Cohort Study of 64,691 Patients.
    Baghdadi JD; Coffey KC; Adediran T; Goodman KE; Pineles L; Magder LS; O'Hara LM; Pineles BL; Nadimpalli G; Morgan DJ; Harris AD
    Antimicrob Agents Chemother; 2021 Oct; 65(11):e0134121. PubMed ID: 34491806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coinfections with Other Respiratory Pathogens among Patients with COVID-19.
    Sreenath K; Batra P; Vinayaraj EV; Bhatia R; SaiKiran K; Singh V; Singh S; Verma N; Singh UB; Mohan A; Bhatnagar S; Trikha A; Guleria R; Chaudhry R
    Microbiol Spectr; 2021 Sep; 9(1):e0016321. PubMed ID: 34287033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands.
    Karami Z; Knoop BT; Dofferhoff ASM; Blaauw MJT; Janssen NA; van Apeldoorn M; Kerckhoffs APM; van de Maat JS; Hoogerwerf JJ; Ten Oever J
    Infect Dis (Lond); 2021 Feb; 53(2):102-110. PubMed ID: 33103530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing the use of empiric antibiotic therapy in COVID-19 on hospital admission.
    Pettit NN; Nguyen CT; Lew AK; Bhagat PH; Nelson A; Olson G; Ridgway JP; Pho MT; Pagkas-Bather J
    BMC Infect Dis; 2021 Jun; 21(1):516. PubMed ID: 34078301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low frequency of community-acquired bacterial co-infection in patients hospitalized for COVID-19 based on clinical, radiological and microbiological criteria: a retrospective cohort study.
    Coenen S; de la Court JR; Buis DTP; Meijboom LJ; Schade RP; Visser CE; van Hest R; Kuijvenhoven M; Prins JM; Nijman SFM; Sieswerda E; Sigaloff KCE
    Antimicrob Resist Infect Control; 2021 Oct; 10(1):155. PubMed ID: 34717761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial Co-Infection and Empirical Antibacterial Therapy in Patients With COVID-19.
    Lee J; Chang E; Jung J; Kim MJ; Chong YP; Kim SH; Lee SO; Choi SH; Kim YS; Bae S
    J Korean Med Sci; 2023 Jan; 38(4):e37. PubMed ID: 36718563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Empiric Antibacterial Therapy, Community-Acquired Bacterial Superinfection, and Antibiotic-Associated Adverse Reactions among Patients with COVID-19 Pneumonia Admitted in Makati Medical Center from March 2020 to March 2021.
    Galang-De Leon WAM; Buensalido JAL
    Infect Chemother; 2022 Jun; 54(2):266-274. PubMed ID: 35706084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study.
    Garcia-Vidal C; Sanjuan G; Moreno-García E; Puerta-Alcalde P; Garcia-Pouton N; Chumbita M; Fernandez-Pittol M; Pitart C; Inciarte A; Bodro M; Morata L; Ambrosioni J; Grafia I; Meira F; Macaya I; Cardozo C; Casals C; Tellez A; Castro P; Marco F; García F; Mensa J; Martínez JA; Soriano A;
    Clin Microbiol Infect; 2021 Jan; 27(1):83-88. PubMed ID: 32745596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difference in the impact of coinfections and secondary infections on antibiotic use in patients hospitalized with COVID-19 between the Omicron-dominant period and the pre-Omicron period.
    Murakami Y; Nozaki Y; Morosawa M; Toyama M; Ogashiwa H; Ueda T; Nakajima K; Tanaka R; Takesue Y
    J Infect Chemother; 2024 Sep; 30(9):853-859. PubMed ID: 38428674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals.
    Seaton RA; Gibbons CL; Cooper L; Malcolm W; McKinney R; Dundas S; Griffith D; Jeffreys D; Hamilton K; Choo-Kang B; Brittain S; Guthrie D; Sneddon J
    J Infect; 2020 Dec; 81(6):952-960. PubMed ID: 32987097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.
    Rawson TM; Moore LSP; Zhu N; Ranganathan N; Skolimowska K; Gilchrist M; Satta G; Cooke G; Holmes A
    Clin Infect Dis; 2020 Dec; 71(9):2459-2468. PubMed ID: 32358954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia.
    Elabbadi A; Turpin M; Gerotziafas GT; Teulier M; Voiriot G; Fartoukh M
    Infection; 2021 Jun; 49(3):559-562. PubMed ID: 33393065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory co-infections in COVID-19-positive patients.
    M Abd El-Halim R; Hafez H; Albahet I; Sherif B
    Eur J Med Res; 2023 Sep; 28(1):317. PubMed ID: 37660059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stewardship Prompts to Improve Antibiotic Selection for Pneumonia: The INSPIRE Randomized Clinical Trial.
    Gohil SK; Septimus E; Kleinman K; Varma N; Avery TR; Heim L; Rahm R; Cooper WS; Cooper M; McLean LE; Nickolay NG; Weinstein RA; Burgess LH; Coady MH; Rosen E; Sljivo S; Sands KE; Moody J; Vigeant J; Rashid S; Gilbert RF; Smith KN; Carver B; Poland RE; Hickok J; Sturdevant SG; Calderwood MS; Weiland A; Kubiak DW; Reddy S; Neuhauser MM; Srinivasan A; Jernigan JA; Hayden MK; Gowda A; Eibensteiner K; Wolf R; Perlin JB; Platt R; Huang SS
    JAMA; 2024 Jun; 331(23):2007-2017. PubMed ID: 38639729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial and fungal growth in sputum cultures from 165 COVID-19 pneumonia patients requiring intubation: evidence for antimicrobial resistance development and analysis of risk factors.
    Liu HH; Yaron D; Piraino AS; Kapelusznik L
    Ann Clin Microbiol Antimicrob; 2021 Sep; 20(1):69. PubMed ID: 34563202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.